In the BioHarmony Drug Report Database
Omadacycline
Nuzyra (omadacycline) is a small molecule pharmaceutical. Omadacycline was first approved as Nuzyra on 2018-10-02. It is used to treat bacterial infections, bacterial pneumonia, and bacterial skin diseases in the USA. Nuzyra’s patents are valid until 2037-10-31 (FDA).
Trade Name
|
Nuzyra |
|---|---|
Common Name
|
omadacycline |
ChEMBL ID
|
CHEMBL1689772 |
Indication
|
bacterial infections, bacterial pneumonia, bacterial skin diseases |
Drug Class
|
Antibiotics (tetracycline derivatives) |
Image (chem structure or protein)